InvestorsHub Logo
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: Kag post# 16731

Thursday, 10/09/2008 10:22:07 AM

Thursday, October 09, 2008 10:22:07 AM

Post# of 30387
Irene Ng**, Janneta Tcherkassova**, Nina Lyubimova***, Ricardo Moro* (rmoro@biocurex.com)

*BioCurex, 215-7080 River Road, Richmond, BC, Canada V6X 1X5

**Pacific Biosciences Research Centre, Richmond BC, Canada

***N.N. Blokhin Cancer Research Centre, Moscow, Russia

Now what? Still in denial?
Everything has to confirmed. There is a process that occurs. I don't think anyone could guess that well. Read the part that says all test were done in a similar matter.
Results: All formats performed in a similar manner (r>0.85). The table below shows the results:

Cancer type
Nr of Cancers
Nr of Normals
Cutoff (Units)
Sensitivity
Specificity

Liver *
15
128
4,900
100%
94%

Pancreatic #
10
50
4,600
100%
95%

Stomach 1st study *
48
40
4,600
90%
98%

Stomach 2nd study *
15
128
4,550
100%
94%

Colorectal &
51
85
4,800
100%
93%




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.